The expression of Fas receptor on cancer cells is increased in the early phase of tumor growth (29, 30), which means that the increased occurrence of CM Tresps expressing membrane-bound Fas-L enables an early effective immune response to cancer. The gene discussed is FASLG; the disease is cancer.